Hepatitis A: all 82 studies

Page 1 of 1. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.

• Study on the Long-Term Persistence of Immunity Induced by Inactivated Hepatitis A VaccineRecruitingNCT07889219
• Risk Factors and Outcomes of Hepatitis A in ChildrenNot yet recruitingNCT07848321
• Comparative Evaluation of Oral Ursodeoxycholic Acid in Reducing Bilirubin Levels Among Patients With Acute Viral HepatitisNot yet recruitingNCT07525401Not applicable
• Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveRecruitingNCT07358910
• the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L VaccinesNot yet recruitingNCT07338851
• Immunity With Acute Hepatits ANot yet recruitingNCT06942962
• Phase IV Study of Concomitant Administration of the sIPV and HepANot yet recruitingNCT06460545Phase 4
• Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and CirrhosisRecruitingNCT06277882Phase 4
• Persistence of Hepatitis A Antibody in Healthy Adults ~32 Years Post Vaccination.Not yet recruitingNCT06184230Phase 4
• Twinrix Pregnancy RegistryCompletedNCT03619590Results posted
• Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3CompletedNCT01808248Phase 2Results posted
• Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate VaccineCompletedNCT01453348Phase 3Results posted
• A Study to Evaluate the Safety and Immunogenicity of the Hepatitis A Virus Vaccine HAVpur in Healthy Young ChildrenCompletedNCT01349829Phase 4Results posted
• Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix AdultCompletedNCT01037114Phase 4Results posted
• Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix AdultCompletedNCT01000324Phase 4Results posted
• Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™CompletedNCT00875485Phase 4Results posted
• Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the PhilippinesCompletedNCT00735644Phase 3Results posted
• Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary VaccinationCompletedNCT00684671Phase 4Results posted
• Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and ChildrenCompletedNCT00621764Phase 2Results posted
• Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)CompletedNCT00326183Phase 4Results posted
• Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month ScheduleCompletedNCT00291876Phase 4Results posted
• Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy AdultsCompletedNCT00289770Phase 3Results posted
• Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month ScheduleCompletedNCT00289757Phase 4Results posted
• Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month ScheduleCompletedNCT00289744Phase 3Results posted
• Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B VaccCompletedNCT00289731Phase 4Results posted
• Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month ScheduleCompletedNCT00289718Phase 3Results posted
• A Randomized Trial of Vaccine Adherence in Young Injection Drug UsersCompletedNCT00244374Not applicableResults posted
• Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 MonthsCompletedNCT00197236Phase 3Results posted
• Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were ComparedCompletedNCT00197184Phase 3Results posted
• Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 YearsCompletedNCT00197119Phase 3Results posted
• Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in ChildrenCompletedNCT00197015Phase 3Results posted
• Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of AgeCompletedNCT00197002Phase 3Results posted
• A Study to Evaluate the 17-Year Immune Persistence of a Single Dose of Inactivated Hepatitis A VaccineCompletedNCT07855705
• Long-term Immunogenicity of L-HAV Vaccine Among Healthy Thai Children and AdolescentsActive, not recruitingNCT07032610
• Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAVActive, not recruitingNCT06978621Phase 3
• Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected PeopleCompletedNCT06576024Phase 4
• Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and AdolescentsCompletedNCT06298708Phase 3
• Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years OldActive, not recruitingNCT06058416Phase 4
• To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Children Aged From 24mons-15yrsStatus unknownNCT05613127Phase 3
• Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021CompletedNCT04939350
• What is the Anti-HAV Seroprevalence of Travelers >60 Years or Having Lived in a Tropical Country for >5 YearsCompletedNCT04638335
• Seroepidemiology of Viral Hepatitis in Hong KongCompletedNCT04371276
• Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected PatientsCompletedNCT03855176Phase 4
• Increasing Healthcare Engagement Via Routine Vaccination Among Young Black Men Who Have Sex With MenWithdrawnNCT03445416Not applicable
• Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A VaccineStatus unknownNCT03330171Phase 4
• Effects of Aging on Primary and Secondary Vaccine ResponsesCompletedNCT03312699Phase 1
• Comparative Immunogenicity Study of Two Hepatitis A VaccinesStatus unknownNCT03231605Phase 4
• Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in IsraelWithdrawnNCT03183492Phase 4
• Hepatitis B in Cystic Fibrosis and Latent Tuberculosis RespectivelyWithdrawnNCT02605538Not applicable
• Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A VaccinesCompletedNCT02601040Phase 4
• Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B VaccineCompletedNCT02445703Phase 4
• The Effects of Honey, as a Dietary Supplement in Children With Hepatitis ACompletedNCT02300792Phase 2
• Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)WithdrawnNCT02135666Phase 4
• Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®WithdrawnNCT02124785Phase 4
• Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in MexicoCompletedNCT02112890
• Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and AdolescentsCompletedNCT02011763Phase 4
• The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy ChildrenCompletedNCT02002065
• The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A VaccinesCompletedNCT01949857Phase 4
• Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young AdultsCompletedNCT01865968Phase 4
• Regulatory Post-Marketing Surveillance Study for Hepatitis A Vaccine (AVAXIM 160U)CompletedNCT01838070
• Safety and Immunogenicity of a Paediatric Dose of Virosomal Hepatitis A VaccineCompletedNCT01405677Phase 2
• Hepatitis A Vaccination in the ElderlyCompletedNCT01353989
• Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) PatientsCompletedNCT01341808Phase 4
• Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR VaccinesCompletedNCT01307436Phase 3
• Immunogenicity and Interchangeability of Two Inactivated Hepatitis A VaccinesCompletedNCT01252680Phase 4
• Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella PertussisCompletedNCT01160081
• Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191CompletedNCT01086709
• Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector DeliveryStatus unknownNCT00926419Phase 2/3
• Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in AdultsCompletedNCT00603252Phase 4
• Safety, Immunogenicity, and Immune Persistence Study of an Inactivated Hepatitis A VaccineCompletedNCT00534885Phase 4
• Immunogenicity and Safety of Sanofi Pasteur's AVAXIM 80U Pediatric Vaccine Followed by Booster DoseCompletedNCT00483470Phase 3
• Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2Status unknownNCT00451984Phase 3
• Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine.CompletedNCT00338351Phase 2
• Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined VaccineCompletedNCT00313950Phase 4
• Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean PopulationCompletedNCT00237991
• Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & ImmunogenicityCompletedNCT00197249Phase 3
• Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B VaccineCompletedNCT00197171Phase 3
• Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected PatientsCompletedNCT00190242Phase 3
• Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis PatientsCompletedNCT00186836Phase 4
• A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis ACompletedNCT00139139Not applicable
• Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young ChildrenCompletedNCT00139113Phase 4
• A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal VaccineTerminatedNCT00119743Phase 3

← Hepatitis A overview